Related Experiment Videos
Human herpesvirus 6 infection
L M Huang1, B D Pfeiffer, C T Cho
1Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, R.O.C.
Insights
Human herpesvirus 6 (HHV-6) is a significant pathogen in young children and immunocompromised individuals, causing various illnesses. Further research is needed to understand its complex host interactions and develop antiviral therapies.
Area of Science:
- Virology
- Immunology
- Pediatrics
Background:
- Human herpesvirus 6 (HHV-6) was discovered in 1986, initially linked to roseola infantum.
- A wide spectrum of clinical syndromes is now associated with HHV-6 infections.
Purpose of the Study:
- To highlight the clinical significance of HHV-6, particularly in specific patient populations.
- To underscore the need for further research into HHV-6 pathogenesis and treatment.
Main Methods:
- This study is a review of existing literature on HHV-6.
- Analysis of clinical data associating HHV-6 with various diseases.
Main Results:
- Age is a critical factor, with HHV-6 being a primary pathogen in children aged 6-24 months.
- HHV-6 is also a significant cause of illness in immunocompromised hosts, including central nervous system ailments.
Conclusions:
- HHV-6 serves as a model for understanding new herpesviruses and their complex interactions with host immune cells.
- Antiviral therapies may benefit immunocompromised patients and those with HHV-6-related central nervous system diseases.
Abstract:
Human herpesvirus 6 (HHV-6) was identified in 1986 and roseola infantum was the first disease linked to HHV-6. To date, a large variety of clinical syndromes have been associated with HHV-6. Age of the patient is the most important factor when considering HHV-6 as a possible cause of infection. It is a major pathogen for children aged 6 to 24 months. In addition, HHV-6 is an important pathogen in the immunocompromised host and may cause ailments of the central nervous system. These later two conditions are most likely to be benefited from the application of anti-viral drug when it becomes available. HHV-6 is an example that virus hides within the immunologic cells and displays a complex interaction with the host cells. The discovery of HHV-6 offers a lesson for clinicians to anticipate new viruses deriving from unexpected sites within the human body; furthermore, HHV-6 provides a model for studying the clinical role of a new herpesvirus.